A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...
Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...
As surgically altered faces become the new normal, it is worth asking who benefits from convincing women that even their ...
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results